LATEST
New Research on Neoantigens and Tumor-targeting T-cells Marks Paradigm Shift in Countering Solid Tumors
2021-11-19
Brigham and Women’s Hospital Initiates First Clinical Trial of Nasal Vaccine for Alzheimer’s Disease
2021-11-18
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
How is China Driving Global Progress in Innovation and Access? – A Discussion with BeiGene CEO John Oyler
2021-11-16
Canadian Regulators Give Go-Ahead for Diabetes Trial Using CRISPR, ViaCyte’s Gene-Edited Stem Cell-Derived Therapy
2021-11-16
Moderna, AstraZeneca Tout Encouraging Trial Data for mRNA-Based Therapeutic in Cardiac Health
2021-11-16